drugset / Trial / NCT06442280

SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

NCT06442280

Phase 4 Unknown 544 enrolled University of Palermo
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the current investigation is to demonstrate the efficacy of high-dose furosemide plus small-volume hypertonic saline solution and a Sodium-Glucose cotransporter-2 (SGLT-2) inhibitor among patients admitted for acute exacerbation of heart failure, in determining a significant increase in diuresis and natriuresis. It is also accompanied by a rapid reduction in body weight and a substantial decrease in hospitalization length without compromising renal function.

Timeline

Start
2024-06
Primary completion
2026-01-31
Completion
2026-03-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 10 mg
Comparator Furosemide Other / unclassified 20 mg Intravenous
Subject Hypertonic Saline Solution Unknown 100 ml Intravenous